Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer

NCT00003489 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Head and Neck Cancer

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute